Bausch Health Americas, Inc.

This study tests whether a new version of the drug rifaximin can delay the first serious brain complication (hepatic encephalopathy) in people with liver cirrhosis and controlled fluid buildup. About 466 adults with cirrhosis but no prior brain episodes will receive either the dr…

This study planned to test an inhaled antiviral drug called Virazole (ribavirin) in hospitalized adults with COVID-19 who had serious breathing trouble. It was a very early Phase 1 trial focused on safety and how well patients improved. However, the study was withdrawn before any…

This Canadian study follows 200 people aged 12 and older with acne who use a prescription gel containing clindamycin, adapalene, and benzoyl peroxide. Researchers want to know how satisfied patients are, how well they stick to the treatment, and how it affects their quality of li…

This Canadian study follows about 394 adults with plaque psoriasis who are starting brodalumab as part of their regular care. Over 12 months, researchers measure changes in skin-related quality of life, work productivity, and treatment satisfaction. The goal is to understand how …

This study tests a next-generation Fraxel laser on 49 adults aged 21-60 with sun damage, skin lesions, or wrinkles around the eyes. Participants get 3 laser treatments, and doctors check if their skin looks better. The goal is to see if the laser is safe and effective for improvi…

This study looks at how safe and tolerable a single dose of brodalumab is for children aged 6 to under 18 with severe plaque psoriasis. It also measures how the drug moves through their bodies. Only 2 children are enrolled, and the main goal is to check the drug's peak level in t…

This study tracks 3,500 adults with moderate-to-severe psoriasis to compare the long-term safety of brodalumab against other standard treatments. Participants are already taking these medications as part of their normal care. The main goal is to see if brodalumab is linked to a h…

This study follows 8,000 children aged 2 to 17 with eczema who have used Elidel cream. Researchers want to see if the cream increases the risk of cancer over 10 years. No new treatment is given—this is an observational study to gather safety information.